126 related articles for article (PubMed ID: 27643643)
1. Concepts in mature T-cell lymphomas - highlights from an international joint symposium on T-cell immunology and oncology.
Herling M; Rengstl B; Scholtysik R; Hartmann S; Küppers R; Hansmann ML; Diebner HH; Roeder I; Abken H; Newrzela S; Kirberg J
Leuk Lymphoma; 2017 Apr; 58(4):788-796. PubMed ID: 27643643
[TBL] [Abstract][Full Text] [Related]
2. Models for mature T-cell lymphomas--a critical appraisal of experimental systems and their contribution to current T-cell tumorigenic concepts.
Warner K; Crispatzu G; Al-Ghaili N; Weit N; Florou V; You MJ; Newrzela S; Herling M
Crit Rev Oncol Hematol; 2013 Dec; 88(3):680-95. PubMed ID: 23972664
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the pathogenesis of T-cell lymphomas.
Van Arnam JS; Lim MS; Elenitoba-Johnson KSJ
Blood; 2018 May; 131(21):2320-2330. PubMed ID: 29666117
[TBL] [Abstract][Full Text] [Related]
4. T-cell therapies for T-cell lymphoma.
Toner K; Bollard CM; Dave H
Cytotherapy; 2019 Sep; 21(9):935-942. PubMed ID: 31320195
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Jiang M; Bennani NN; Feldman AL
Expert Rev Hematol; 2017 Mar; 10(3):239-249. PubMed ID: 28133975
[TBL] [Abstract][Full Text] [Related]
6. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
7. Novel Immunotherapies for T Cell Lymphoma and Leukemia.
Ghione P; Moskowitz AJ; De Paola NEK; Horwitz SM; Ruella M
Curr Hematol Malig Rep; 2018 Dec; 13(6):494-506. PubMed ID: 30317410
[TBL] [Abstract][Full Text] [Related]
8. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009.
Kwong YL; Anderson BO; Advani R; Kim WS; Levine AM; Lim ST;
Lancet Oncol; 2009 Nov; 10(11):1093-101. PubMed ID: 19880063
[TBL] [Abstract][Full Text] [Related]
9. Molecular predictors of response in aggressive T-cell lymphomas.
Foss FM
Cancer J; 2011; 17(2):142-8. PubMed ID: 21427558
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.
Lynch A; Hawk W; Nylen E; Ober S; Autin P; Barber A
Immunology; 2017 Nov; 152(3):472-483. PubMed ID: 28670716
[TBL] [Abstract][Full Text] [Related]
11. [Progress in the treatment of mature T-cell lymphoma].
Suzuki R
Rinsho Ketsueki; 2016; 57(10):2000-2007. PubMed ID: 27795507
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.
Knowles DM
Am J Pathol; 1989 Apr; 134(4):761-85. PubMed ID: 2495724
[TBL] [Abstract][Full Text] [Related]
13. Gamma-delta t-cell lymphomas.
Foppoli M; Ferreri AJ
Eur J Haematol; 2015 Mar; 94(3):206-18. PubMed ID: 25154298
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 and antibody to the T cell receptor regulate proliferation of a radiation leukemia virus-transformed T cell lymphoma.
O'Neill HC
Leukemia; 1988 Feb; 2(2):108-14. PubMed ID: 2830440
[TBL] [Abstract][Full Text] [Related]
15. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.
Brüggemann M; White H; Gaulard P; Garcia-Sanz R; Gameiro P; Oeschger S; Jasani B; Ott M; Delsol G; Orfao A; Tiemann M; Herbst H; Langerak AW; Spaargaren M; Moreau E; Groenen PJ; Sambade C; Foroni L; Carter GI; Hummel M; Bastard C; Davi F; Delfau-Larue MH; Kneba M; van Dongen JJ; Beldjord K; Molina TJ
Leukemia; 2007 Feb; 21(2):215-21. PubMed ID: 17170730
[TBL] [Abstract][Full Text] [Related]
16. Pathobiology of mature T-cell lymphomas.
Cotta CV; Hsi ED
Clin Lymphoma Myeloma; 2008 Dec; 8 Suppl 5():S168-79. PubMed ID: 19073524
[TBL] [Abstract][Full Text] [Related]
17. Rearrangement of the T-cell receptor delta chain gene in T-cell lymphomas with a mature phenotype.
van Krieken JH; Elwood L; Andrade RE; Jaffe ES; Cossman J; Medeiros LJ
Am J Pathol; 1991 Jul; 139(1):161-8. PubMed ID: 1830192
[TBL] [Abstract][Full Text] [Related]
18. Pathology of T-cell lymphomas: diagnosis and biomarker discovery.
Gru AA
Cancer Treat Res; 2015; 165():51-95. PubMed ID: 25655606
[TBL] [Abstract][Full Text] [Related]
19. T-cell receptor diversity prevents T-cell lymphoma development.
Newrzela S; Al-Ghaili N; Heinrich T; Petkova M; Hartmann S; Rengstl B; Kumar A; Jäck HM; Gerdes S; Roeder I; Hansmann ML; von Laer D
Leukemia; 2012 Dec; 26(12):2499-507. PubMed ID: 22643706
[TBL] [Abstract][Full Text] [Related]
20. An evolutionary stability perspective on oncogenesis control in mature T-cell populations.
Diebner HH; Kirberg J; Roeder I
J Theor Biol; 2016 Jan; 389():88-100. PubMed ID: 26549469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
